Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Haemonetics reveals 18 per cent rise in net revenues

Haemonetics reveals 18 per cent rise in net revenues

6th February 2009

Haemonetics has revealed its year to date net revenues have risen 18 per cent.

Now standing at $445 million (303 million pounds), the figure was joined by a 35 per cent growth in operating income to $67 million over the same period.

The company also announced in its third-quarter fiscal 2009 results that net earnings per share were up 15 per cent to $0.62.

Commenting on the figures, Haemonetics’ chairman and chief executive officer Brad Nutter said the company was “seeing strength” in its diversified product lines, despite the current economic climate.

He added: “I’m particularly pleased to note that year-to-date reported revenue growth is double digits in all of our geographies.”

Mr Nutter went on to note the company’s outlook for the future was “strong”.

In October last year, the organisation announced its generally accepted accounting principle net revenues were up 20 per cent to $146 million, while its operating income increased 62 per cent to $24 million.

We currently have 5 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.